• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们能否识别出有发展为多发性骨髓瘤风险的个体?一种基于机器学习的预测模型。

Can we identify individuals at risk to develop multiple myeloma? A machine learning-based predictive model.

作者信息

Mittelman Moshe, Israel Ariel, Oster Howard S, Leshchinsky Michael, Ben-Shlomo Yatir, Kepten Eldad, Dolberg Osnat Jarchowsky, Balicer Ran, Shaham Galit

机构信息

Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Br J Haematol. 2025 Aug;207(2):387-394. doi: 10.1111/bjh.20136. Epub 2025 Jun 16.

DOI:10.1111/bjh.20136
PMID:40524461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12378918/
Abstract

Multiple myeloma evolves unnoticed over years, and when diagnosed, organ damage is common. Electronic health records (EHR) can help in developing predictive models identifying 'healthy' people at risk. MM patients from Clalit Health Services (2002-2019) were matched with healthy controls. Stage I: EHR from 5 years prior to MM diagnosis were reviewed and >200 parameters were compared (patients vs. controls). Stage II: Establishing xgboost model predicting 5 year risk for MM, with validation. Stage III: A simplified logistic regression model for community, requiring 20 variables (Age; Hb; RBC; MCV; RDW; WBC; neutrophils; lymphocytes; monocytes; basophils; glucose; creatinine; total protein; albumin; calcium; uric acid; bilirubin; HDL-C; LDL-C; triglycerides). EHR from the pre-MM period of 4256 patients were compared to controls. Future MM patients had higher ESR, lower Hb, ANC, neutrophil/lymphocyte ratio, higher globulins and ferritin, more immune deficiencies, MDS and FMF. They took fewer tranquilizers, anti-diabetics and statins. Using labs from future MM (n = 19 129) and controls (n = 382 580, 20:1), a predictive model was developed (ROC AUC = 0.836). The simple LR model provided individual risk prediction for MM within 5 years (AUC = 0.72). Two models with machine learning predict the risk of myeloma in 'healthy' individuals within 5 years. The models can be used in practice.

摘要

多发性骨髓瘤多年来悄然发展,确诊时器官损害很常见。电子健康记录(EHR)有助于开发预测模型,识别有风险的“健康”人群。将克拉利特医疗服务机构(2002 - 2019年)的多发性骨髓瘤患者与健康对照进行匹配。第一阶段:回顾多发性骨髓瘤诊断前5年的电子健康记录,并比较200多个参数(患者与对照)。第二阶段:建立预测多发性骨髓瘤5年风险的xgboost模型并进行验证。第三阶段:建立一个适用于社区的简化逻辑回归模型,需要20个变量(年龄;血红蛋白;红细胞;平均红细胞体积;红细胞分布宽度;白细胞;中性粒细胞;淋巴细胞;单核细胞;嗜碱性粒细胞;葡萄糖;肌酐;总蛋白;白蛋白;钙;尿酸;胆红素;高密度脂蛋白胆固醇;低密度脂蛋白胆固醇;甘油三酯)。将4256例患者骨髓瘤前期的电子健康记录与对照进行比较。未来的多发性骨髓瘤患者血沉较高,血红蛋白、中性粒细胞绝对值、中性粒细胞/淋巴细胞比值较低,球蛋白和铁蛋白较高,免疫缺陷、骨髓增生异常综合征和家族性地中海热更多见。他们服用的镇静剂、抗糖尿病药和他汀类药物较少。利用未来多发性骨髓瘤患者(n = 19129)和对照(n =​​ 382580,比例为20:1)的实验室检查结果,开发了一个预测模型(ROC曲线下面积= 0.836)。简单逻辑回归模型可提供5年内个体患多发性骨髓瘤的风险预测(曲线下面积= 0.72)。两个机器学习模型可预测“健康”个体5年内患骨髓瘤的风险。这些模型可应用于实际。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/12378918/83001972ac1a/BJH-207-387-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/12378918/8e15cf40e2ca/BJH-207-387-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/12378918/83001972ac1a/BJH-207-387-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/12378918/8e15cf40e2ca/BJH-207-387-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/12378918/83001972ac1a/BJH-207-387-g003.jpg

相似文献

1
Can we identify individuals at risk to develop multiple myeloma? A machine learning-based predictive model.我们能否识别出有发展为多发性骨髓瘤风险的个体?一种基于机器学习的预测模型。
Br J Haematol. 2025 Aug;207(2):387-394. doi: 10.1111/bjh.20136. Epub 2025 Jun 16.
2
Development of Machine Learning-based Algorithms to Predict the 2- and 5-year Risk of TKA After Tibial Plateau Fracture Treatment.基于机器学习的算法用于预测胫骨平台骨折治疗后2年和5年全膝关节置换风险的研究进展
Clin Orthop Relat Res. 2025 Mar 12. doi: 10.1097/CORR.0000000000003442.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Construction of a treatment response prediction model for multiple myeloma based on multi-omics and machine learning.基于多组学和机器学习构建多发性骨髓瘤治疗反应预测模型
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Apr 28;50(4):531-544. doi: 10.11817/j.issn.1672-7347.2025.240691.
6
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.
7
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
8
Supervised Machine Learning Models for Predicting Sepsis-Associated Liver Injury in Patients With Sepsis: Development and Validation Study Based on a Multicenter Cohort Study.用于预测脓毒症患者脓毒症相关肝损伤的监督式机器学习模型:基于多中心队列研究的开发与验证研究
J Med Internet Res. 2025 May 26;27:e66733. doi: 10.2196/66733.
9
Construction of a machine learning-based screening model for IgD myeloma.基于机器学习的IgD骨髓瘤筛查模型的构建。
Clin Chim Acta. 2025 Sep 1;577:120488. doi: 10.1016/j.cca.2025.120488. Epub 2025 Jul 15.
10
A prognostic model for multiple myeloma based on lipid metabolism related genes.基于脂质代谢相关基因的多发性骨髓瘤预后模型
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Apr 28;50(4):517-530. doi: 10.11817/j.issn.1672-7347.2025.240592.

引用本文的文献

1
Challenges, Difficulties, and Delayed Diagnosis of Multiple Myeloma.多发性骨髓瘤的挑战、困难及诊断延误
Diagnostics (Basel). 2025 Jul 4;15(13):1708. doi: 10.3390/diagnostics15131708.

本文引用的文献

1
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.达雷妥尤单抗或高危冒烟型多发性骨髓瘤的主动监测
N Engl J Med. 2025 May 8;392(18):1777-1788. doi: 10.1056/NEJMoa2409029. Epub 2024 Dec 9.
2
Myeloma Therapy for Monoclonal Gammopathy of Thrombotic Significance.具有血栓形成意义的单克隆丙种球蛋白病的骨髓瘤治疗
N Engl J Med. 2024 Aug 8;391(6):570-571. doi: 10.1056/NEJMc2406453.
3
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities.多发性骨髓瘤的蛋白质基因组全景揭示了疾病生物学和治疗机会的新见解。
Nat Cancer. 2024 Aug;5(8):1267-1284. doi: 10.1038/s43018-024-00784-3. Epub 2024 Jun 28.
4
Smoldering multiple myeloma: taking the narrow over the wide path?冒烟型多发性骨髓瘤:走狭窄路还是宽广路?
Blood. 2024 May 16;143(20):2025-2028. doi: 10.1182/blood.2024023880.
5
Artificial Intelligence in Medicine.医学中的人工智能
N Engl J Med. 2023 Mar 30;388(13):1220-1221. doi: 10.1056/NEJMe2206291.
6
Artificial Intelligence and Machine Learning in Clinical Medicine, 2023.临床医学中的人工智能与机器学习,2023年。
N Engl J Med. 2023 Mar 30;388(13):1201-1208. doi: 10.1056/NEJMra2302038.
7
How I approach smoldering multiple myeloma.我是如何处理冒烟型多发性骨髓瘤的。
Blood. 2022 Aug 25;140(8):828-838. doi: 10.1182/blood.2021011670.
8
Identification of biomarkers for early diagnosis of multiple myeloma by weighted gene co-expression network analysis and their clinical relevance.基于加权基因共表达网络分析鉴定多发性骨髓瘤早期诊断的生物标志物及其临床相关性。
Hematology. 2022 Dec;27(1):322-331. doi: 10.1080/16078454.2022.2046326.
9
Diagnosis and Management of Multiple Myeloma: A Review.多发性骨髓瘤的诊断与治疗:综述
JAMA. 2022 Feb 1;327(5):464-477. doi: 10.1001/jama.2022.0003.
10
Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic events.MGUS 的诊断、风险分层和管理进展:介绍骨髓瘤定义性基因组事件。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):662-672. doi: 10.1182/hematology.2021000303.